Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Infection in 2019 (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05406908
What this trial is testing

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Who this might be right for
Bullous DermatosesPsoriasisCOVID-19 Vaccines
Mahidol University 109
Early research (Phase 1)Study completedNCT04516564
What this trial is testing

AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Akesobio Australia Pty Ltd 29
Not applicableStudy completedNCT04359212
What this trial is testing

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

Who this might be right for
COVID-19 DiseaseThromboembolism, Venous
Quovadis Associazione 90
Not applicableStudy completedNCT04335019
What this trial is testing

Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +

Who this might be right for
2019-nCoV (COVID-19)Interstitial Pneumonia
Assistance Publique - Hôpitaux de Paris 328
Testing effectiveness (Phase 2)Study completedNCT04678830
What this trial is testing

Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19

Who this might be right for
Coronavirus Disease 2019
CytoDyn, Inc. 56
Not applicableStudy completedNCT04383730
What this trial is testing

Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)

Who this might be right for
Critically IllnessSedationInvasive Mechanical Ventilation+1 more
University Hospital, Clermont-Ferrand 203
Testing effectiveness (Phase 2)Study completedNCT04409509
What this trial is testing

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
CSL Behring 124
Not applicableStudy completedNCT06170320
What this trial is testing

STREngthening COronavirus Disease 2019 (COVID-19) Surveillance in Africa

Who this might be right for
COVID-19SARS CoV 2 InfectionCOVID-19 Pandemic
Institut de Recherche pour le Developpement 7,000
Testing effectiveness (Phase 2)Ended earlyNCT05451654
What this trial is testing

NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19 Pandemic
Medesis Pharma SA 7
Testing effectiveness (Phase 2)Study completedNCT04359654
What this trial is testing

Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 (Coronavirus Disease 2019)Hypoxia
University College, London 41
Not applicableStudy completedNCT04760561
What this trial is testing

Awake Prone Positioning for Non-intubated COVID-19 Patients

Who this might be right for
Prone PositionCoronavirus Disease 2019Oxygenation
Damanhour University 82
Not applicableStudy completedNCT04424017
What this trial is testing

Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

Who this might be right for
COVIDCorona Virus Infection
Egyptian Center for Research and Regenerative Medicine 1,546
Early research (Phase 1)WithdrawnNCT04425733
What this trial is testing

Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)PneumoniaHypoxemia
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT04317040
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 234
Post-approval studies (Phase 4)UnknownNCT04308317
What this trial is testing

Tetrandrine Tablets Used in the Treatment of COVID-19

Who this might be right for
Corona Virus Disease 2019,COVID-19
Henan Provincial People's Hospital 60
Not applicableUnknownNCT04273763
What this trial is testing

Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Who this might be right for
Novel Coronavirus Pneumonia2019-nCoV
Second Affiliated Hospital of Wenzhou Medical University 18
Not applicableUnknownNCT05216471
What this trial is testing

Identify Coronavirus Disease by Chest X-ray

Who this might be right for
Coronavirus Disease 2019
Assiut University 150
Testing effectiveness (Phase 2)Ended earlyNCT04391309
What this trial is testing

COVID-19 and Anti-CD14 Treatment Trial

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT04838834
What this trial is testing

Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children

Who this might be right for
COVID-19SARS-CoV-2Inflammatory Bowel Diseases
Connecticut Children's Medical Center 472
Testing effectiveness (Phase 2)Ended earlyNCT04788459
What this trial is testing

Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

Who this might be right for
COVID-19Protection Against COVID-19 and Infections With SARS-CoV- 2COVID-19 Immunisation
Takis 68
Next Page